A new TMHA-DHPLC assay for the rapid mutation screening of JAK2 exon 14 in myeloproliferative disorders

American Journal of Hematology

Volumn 83, Issue 7, 2008, Pages 603-604

  Albiero, Elena ^a   Bernardi, Martina ^a   Madeo, Domenico ^a   Ruggeri, Marco ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; JANUS KINASE 2; NUCLEOTIDE;

ALLELE; AMPLICON; BLOOD; CLINICAL PRACTICE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HETERODUPLEX ANALYSIS; LETTER; MELTING POINT; MYELOPROLIFERATIVE DISORDER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WILD TYPE;

EID: 45749127926     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21116     Document Type: Letter

References (3)

1. Schnittger S, Bacher U, Kern W, et al. Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E. Leukemia 2006;20:2195-2197.
2. Grunebach F, Bross-Bach U, Kanz L, et al. Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera. Leukemia 2006;20:2210-2211.
3. Stevenson WS, Hoyt R, Bell A, et al. Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: Implications for mutation detection in peripheral blood. Pathology 2006;38:336-342.